The presence of CD8+ T cell clones specific for prostate cancer epitopes has been reported among healthy individuals and in early-stage disease, whereas IFN-γ expression in CD8+ T cells from advanced-stage prostate cancer patients tends to be very low or absent.23 The gene discussed is CD8A; the disease is prostate carcinoma.